Literature DB >> 27840427

PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia.

D Goltz1, H Gevensleben1, S Grünen1, J Dietrich2, G Kristiansen1, J Landsberg3, D Dietrich1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27840427     DOI： 10.1038/leu.2016.328

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  33 in total

1.  PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients.

Authors:  Diane Goltz; Heidrun Gevensleben; Jörn Dietrich; Dimo Dietrich
Journal:  Oncoimmunology       Date:  2016-11-10       Impact factor: 8.110

Review 2.  Acute myeloid leukemia and NK cells: two warriors confront each other.

Authors:  Aroa Baragaño Raneros; Carlos López-Larrea; Beatriz Suárez-Álvarez
Journal:  Oncoimmunology       Date:  2018-10-31       Impact factor: 8.110

Review 3.  Cancer Epigenetics, Tumor Immunity, and Immunotherapy.

Authors:  Jian Cao; Qin Yan
Journal:  Trends Cancer       Date:  2020-03-31

Review 4.  Immunological effects of hypomethylating agents.

Authors:  Katherine E Lindblad; Meghali Goswami; Christopher S Hourigan; Karolyn A Oetjen
Journal:  Expert Rev Hematol       Date:  2017-07-03       Impact factor: 2.929

Review 5.  Deciphering DNA Methylation in HIV Infection.

Authors:  Thilona Arumugam; Upasana Ramphal; Theolan Adimulam; Romona Chinniah; Veron Ramsuran
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

6.  Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.

Authors:  Anne Fröhlich; Judith Sirokay; Simon Fietz; Timo J Vogt; Jörn Dietrich; Romina Zarbl; Mike Florin; Pia Kuster; Gonzalo Saavedra; Susana Ramírez Valladolid; Friederike Hoffmann; Lukas Flatz; Sandra S Ring; Carsten Golletz; Torsten Pietsch; Sebastian Strieth; Peter Brossart; Gerrit H Gielen; Glen Kristiansen; Friedrich Bootz; Jennifer Landsberg; Dimo Dietrich
Journal:  EBioMedicine       Date:  2020-08-30       Impact factor: 8.143

7.  PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival.

Authors:  Goran Micevic; Durga Thakral; Meaghan McGeary; Marcus W Bosenberg
Journal:  Pigment Cell Melanoma Res       Date:  2018-11-22       Impact factor: 4.693

8.  CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients.

Authors:  Diane Goltz; Heidrun Gevensleben; Timo J Vogt; Joern Dietrich; Carsten Golletz; Friedrich Bootz; Glen Kristiansen; Jennifer Landsberg; Dimo Dietrich
Journal:  JCI Insight       Date:  2018-07-12

9.  Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5'-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients.

Authors:  Timo J Vogt; Heidrun Gevensleben; Jörn Dietrich; Glen Kristiansen; Friedrich Bootz; Jennifer Landsberg; Diane Goltz; Dimo Dietrich
Journal:  Oncoimmunology       Date:  2018-04-18       Impact factor: 8.110

Review 10.  Understanding LAG-3 Signaling.

Authors:  Luisa Chocarro; Ester Blanco; Miren Zuazo; Hugo Arasanz; Ana Bocanegra; Leticia Fernández-Rubio; Pilar Morente; Gonzalo Fernández-Hinojal; Miriam Echaide; Maider Garnica; Pablo Ramos; Ruth Vera; Grazyna Kochan; David Escors
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.